| Property |
Value |
| dbo:abstract
|
- L'amifostine est un adjuvant cytoprotecteur utilisé en chimiothérapie du cancer impliquant des agents chimiothérapeutiques liant l'ADN. Portion de texte anglais à traduire en français Texte anglais à traduire :Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including (e.g. cyclophosphamide) and platinum-containing agents (e.g. ). It is also used to decrease the cumulative nephrotoxicity associated with platinum-containing agents. Amifostine is also indicated to reduce the incidence of xerostomia in patients undergoing radiotherapy for head and neck cancer. Amifostine is an organic thiophosphate which is dephosphorylated in vivo by to the active cytoprotective thiol metabolite. The selective protection of non-malignant tissues is believed to be due to higher alkaline phosphatase activity, higher pH, and vascular permeation of normal tissues. Traduire ce texte • Outils • (+) (fr)
- L'amifostine est un adjuvant cytoprotecteur utilisé en chimiothérapie du cancer impliquant des agents chimiothérapeutiques liant l'ADN. Portion de texte anglais à traduire en français Texte anglais à traduire :Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including (e.g. cyclophosphamide) and platinum-containing agents (e.g. ). It is also used to decrease the cumulative nephrotoxicity associated with platinum-containing agents. Amifostine is also indicated to reduce the incidence of xerostomia in patients undergoing radiotherapy for head and neck cancer. Amifostine is an organic thiophosphate which is dephosphorylated in vivo by to the active cytoprotective thiol metabolite. The selective protection of non-malignant tissues is believed to be due to higher alkaline phosphatase activity, higher pH, and vascular permeation of normal tissues. Traduire ce texte • Outils • (+) (fr)
|
| dbo:einecsNumber
| |
| dbo:inchi
|
- 1/C5H15N2O3PS/c6-2-1-3-7-4-5-12-11(8,9)10/h7H,1-6H2,(H2,8,9,10)
|
| dbo:iupacName
|
- S-{2-[(3-aminopropyl)amino]éthyl} dihydrogénophosphorothioate (fr)
- S-{2-[(3-aminopropyl)amino]éthyl} dihydrogénophosphorothioate (fr)
|
| dbo:smiles
| |
| dbo:thumbnail
| |
| dbo:weight
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 4781 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| prop-fr:c
| |
| prop-fr:h
| |
| prop-fr:inchi
| |
| prop-fr:n
| |
| prop-fr:nom
|
- Amifostine (fr)
- Amifostine (fr)
|
| prop-fr:nomiupac
|
- S-{2-[amino]éthyl} dihydrogénophosphorothioate (fr)
- S-{2-[amino]éthyl} dihydrogénophosphorothioate (fr)
|
| prop-fr:o
| |
| prop-fr:p
| |
| prop-fr:s
| |
| prop-fr:smiles
|
- NCCCNCCSPO (fr)
- NCCCNCCSPO (fr)
|
| prop-fr:tailleImage
| |
| prop-fr:wikiPageUsesTemplate
| |
| dct:subject
| |
| rdf:type
| |
| rdfs:comment
|
- L'amifostine est un adjuvant cytoprotecteur utilisé en chimiothérapie du cancer impliquant des agents chimiothérapeutiques liant l'ADN. Portion de texte anglais à traduire en français Texte anglais à traduire :Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including (e.g. cyclophosphamide) and platinum-containing agents (e.g. ). It is also used to decrease the cumulative nephrotoxicity associated with platinum-containing agents. Amifostine is also indicated to reduce the incidence of xerostomia in patients undergoing radiotherapy for head and neck cancer. (fr)
- L'amifostine est un adjuvant cytoprotecteur utilisé en chimiothérapie du cancer impliquant des agents chimiothérapeutiques liant l'ADN. Portion de texte anglais à traduire en français Texte anglais à traduire :Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including (e.g. cyclophosphamide) and platinum-containing agents (e.g. ). It is also used to decrease the cumulative nephrotoxicity associated with platinum-containing agents. Amifostine is also indicated to reduce the incidence of xerostomia in patients undergoing radiotherapy for head and neck cancer. (fr)
|
| rdfs:label
|
- Amifostine (fr)
- Amifostin (de)
- Amifostina (pt)
- Amifostine (vi)
- Amifostine (fr)
- Amifostin (de)
- Amifostina (pt)
- Amifostine (vi)
|
| rdfs:seeAlso
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Amifostine (fr)
- Amifostine (fr)
|
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is oa:hasTarget
of | |
| is foaf:primaryTopic
of | |
